🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💫AMPC 2025 Director of Communications Roy van der Meel, Ph.D. shares exciting advancements shaping the future of controlled release science during the CRS 2025 Annual Meeting & Exposition, register now: ow.ly/8E5I50VuF32 Tips for exploring Philadelphia: discoverPHL

We're hiring! Looking for a postdoc in organic chemistry with a focus on lipid synthesis. Exciting projects in nanomedicine & drug delivery. DM me if you're interested or know someone great! #Postdoc #Chemistry #LipidScience #DrugDelivery

What a great first day of the NanoTME 2025 Meeting (nanotme.nl) organized by Jai Prakash and Yuval Shaked including inspiring talks by Assaf Zinger on biomimetic #nanoparticles and Dan Peer on #LNP enabling nucleic acid therapeutics!

Standing room only for Mikhail Shapiro (same on bsky) 🇺🇦's talk at the TU Eindhoven #Bioengineering Symposium!

How to write and publish an impactful paper 🗞? Christine Horejs from Nature Reviews Bioengineering explains at the TU Eindhoven #Bioengineering Symposium

Great talk as always by Twan Lammers on translating #cancer #nanomedicine at the TU Eindhoven #Bioengineering Symposium

Nothing beats a hardcopy📰, especially of a study that’s been in the works for half a decade. Congrats👏🏼 to Roy van der Meel, Stijn Hofstraat, Tom Anbergen and our awesome team & collaborators. Nature Nanotechnology TU Eindhoven Radboudumc

A gene-editing treatment used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases #NBTNewsBeat nytimes.com/2025/05/15/hea…

📢 Final call to submit your abstract and register for our #ImmunoEngineering Symposium! 🌟 Join us i3S-Instituto de Investigação e Inovação em Saúde and take advantage of this exceptional #networking opportunity—don’t miss out! 🗓️16-18 May ➡️ bit.ly/4fYZVH9

Another medical milestone! The first patient treated with a prime edited therapeutic shows positive clinical outcomes consistent with effective rescue of his chronic granulomatous disease (CGD), a debilitating and life-shortening primary immunodeficiency. At least 19 base editing

Happy people dancing🕺🏽 at the MulderLab weekend. Thanks to DJ Justus’ brilliant performance. 🙏🏼Joost Kreijtz 🎶🎧

We had another awesome Friesland weekend with our lab, associated companies & friends. Although the weather was 🌧️&💨, everyone had a good time. DJ Justus Joost Kreijtz made sure of that! Here’s a highlight video;

Dual SORT LNPs for multi-organ base editing go.nature.com/3HC9EHt

🧬 DNA isn't just for biology anymore! Our new comment paper in Nature Nanotechnology explores how DNA molecules are revolutionizing computing & data storage: rdcu.be/eqjfn

Next-generation materials for nucleic acid delivery! Now in NatRevMaterials Our viewpoint on the future synthetic carriers for therapeutic nucleic acids. Read it here: nature.com/articles/s4157…

Second day of MOBILIsE symposium with the enthusiastic Roy van der Meel showcasing the power of natural #lipoproteins for delivering RNA to immune cells. Feeling fortunate for attending such as an inspirational talk! 🍀 ☀️

🚨NEW - In vivo CAR T cell generation to treat cancer and autoimmune disease Capstan Therapeutics direct delivery of mRNA-encoded CARs to CD8+ T cells in mouse & NHP models shows tumor control not only in blood, but also tissue. Immune reset seen at B cell recovery science.org/doi/10.1126/sc…

Lipid nanoparticle screening in nonhuman primates with minimal loss of life bit.ly/3I0TO9A

Here you can read about our RNA delivery nanotechnology from PhD student Stijn Hofstraat's vantage point in the ICMS magazine. Very cool graphics by ICMS's animation studio. tue.nl/en/research/re… tue.nl/en/research/re…

The first cancer vaccines matched to a person’s unique tumor neoantigens are forging ahead, with expectations running high as the field awaits results from the first pivotal trial nature.com/articles/s4158… rdcu.be/euaoK